Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00792155 · ClinicalTrials.gov registry record

Polycystic Kidney Disease Data Repository

A clinical trial of Polycystic Kidney Disease, sponsored by The Rogosin Institute.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT00792155 is a study of Polycystic Kidney Disease that is actively recruiting participants, run by The Rogosin Institute. The registered enrollment target is 1,000 participants, above the 133-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (652% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00792155, a study of Polycystic Kidney Disease, is actively recruiting participants, sponsored by The Rogosin Institute.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all PKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even among members of the same family. Despite the fact this is a relatively common problem, relatively few patients have been studied for a sufficient period of time to fully understand how patients are affected over the course of their lifetime. The reason for creating this repository is to collect information about PKD so that the investigators may fully understand its complications, including high blood pressure, heart attack, and stroke. This information may also aid in the development of improved treatment strategies.

Conditions Studied

Study Locations (1)

New York

  • The Rogosin Institute - New York

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2002-11
Est. Completion 2030-12

Sponsor

The Rogosin Institute

21 total trials

What the Registry Record Tells You About NCT00792155

The ClinicalTrials.gov registry entry for NCT00792155 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 133-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (652% higher). The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00792155 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00792155 about?

NCT00792155 is a clinical study titled "Polycystic Kidney Disease Data Repository". Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all PKD patients d...

What is the current status of trial NCT00792155?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2002-11. Estimated completion is 2030-12.

What conditions does trial NCT00792155 study?

This clinical trial studies the following conditions: Polycystic Kidney Disease.

Who is sponsoring clinical trial NCT00792155?

This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00792155 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Polycystic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.